Maia Wealth LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 380 shares of the biotechnology company’s stock, valued at approximately $230,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Prestige Wealth Management Group LLC boosted its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. New Wave Wealth Advisors LLC bought a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $40,000. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise in the third quarter valued at approximately $41,000. Y.D. More Investments Ltd bought a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $45,000. Finally, Planning Capital Management Corp boosted its position in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Activity
In other news, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Jeffrey C. Kunins sold 1,370 shares of the firm’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $639.14, for a total value of $875,621.80. Following the completion of the sale, the insider now owns 125,950 shares of the company’s stock, valued at approximately $80,499,683. This trade represents a 1.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,407 shares of company stock worth $4,122,925. 6.10% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Get Our Latest Research Report on AXON
Axon Enterprise Stock Down 0.5 %
Shares of NASDAQ AXON opened at $525.75 on Tuesday. The stock has a market cap of $40.09 billion, a PE ratio of 135.85, a PEG ratio of 5.17 and a beta of 1.05. The business has a fifty day moving average of $607.58 and a two-hundred day moving average of $526.43. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- What is the Nikkei 225 index?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Stock Market Sectors: What Are They and How Many Are There?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.